Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids

Journal of Cellular Biochemistry

Volumn 88, Issue 1, 2003, Pages 83-94

  Roninson, Igor B ^a   Dokmanovic, Milos ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cancer chemotherapy; Retinoids; Senescence; Tumor suppressor genes

Indexed keywords

ALITRETINOIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P73; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; TRANSFORMING GROWTH FACTOR BETA1;

BREAST CARCINOMA; CANCER CELL; CANCER CHEMOTHERAPY; CELL GROWTH; CELL STRAIN MCF 7; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVIEW; SENESCENCE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL AGING; CELL DIFFERENTIATION; HUMANS; NEOPLASMS; NEUROBLASTOMA; RETINOIDS; TIME FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037214472     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10320     Document Type: Review

References (106)

1. Adachi H, Preston G, Harvat B, Dawson MI, Jetten AM. 1998. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am J Respir Cell Mol Biol 18:323-333.
2. Adamo ML, Shao ZM, Lanau F, Chen JC, Clemmons DR, Roberts CT, Jr., LeRoith D, Fontana JA. 1992. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131:1858-1866.
3. Agarwal C, Chandraratna RA, Teng M, Nagpal S, Rorke EA, Eckert RL. 1996. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor. Cell Growth Differ 7:521-530.
4. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 93:13742-13747.
5. Altucci L, Gronemeyer H. 2001. The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181-193.
6. Andreatta-Van Leyen S, Hembree JR, Eckert RL. 1994. Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. J Cell Physiol 160:265-274.
7. Andrews PW. 1984. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103:285-293.
8. Babajko S, Binoux M. 1996. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 134:474-480.
9. Bartsch D, Boye B, Baust C, zur HH, Schwarz E. 1992. Retinoic acid-mediated repression of human papilloma-virus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11:2283-2291.
10. Bovenzi V, Momparler RL. 2001. Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Cancer Chemother Pharmacol 48:71-76.
11. Bringold F, Serrano M. 2000. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35:317-329.
12. Campisi J. 2000. Cancer, aging, and cellular senescence. In Vivo 14:183-188.
13. Carpentier AF, Leonard N, Lacombe J, Zassadowski F, Padua RA, Degos L, Daumas-Duport C, Chomienne C. 1999. Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines. Anticancer Res 19:3189-3192.
14. Casini T, Pelicci PG. 1999. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene 18:3235-3243.
15. Chambery D, de Galle B, Babajko S. 1998. Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells. J Endocrinol 159:227-232.
16. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
17. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB. 1999a. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59:3761-3767.
18. waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18:4808-4818.
19. war1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 97:4291-4296.
20. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. 2002. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic drug. Proc Natl Acad Sci USA 99:389-394.
21. Chen YH, Lavelle D, Desimone J, Uddin S, Platanias LC, Hankewych M. 1999. Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1). Blood 94:251-259.
22. Clagett-Dame M, Verhalen TJ, Biedler JL, Repa JJ. 1993. Identification and characterization of all-trans-retinoic acid receptor transcripts and receptor protein in human neuroblastoma cells. Arch Biochem Biophys 300:684-693.
23. De Laurenzi V, Raschella G, Barcaroli D, Annicchiarico-Petruzzelli M, Ranalli M, Catani MV, Tanno B, Costanzo A, Levrero M, Melino G. 2000. Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem 275:15226-15231.
24. de The H, Marchio A, Tiollais P, Dejean A. 1989. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO J 8:429-433.
25. Defacque H, Piquemal D, Basset A, Marti J, Commes T. 1999. Transforming growth factor-beta1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. J Cell Physiol 178: 109-119.
26. Demary K, Wong L, Spanjaard RA. 2001. Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation, and inhibition of proliferation of melanoma cells. Cancer Lett 163:103-107.
27. Di Leonardo A, Linke SP, Clarkin K, Wahl GM. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8:2540-2551.
28. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo PC, Del Vecchio L. 1994. All-trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells. Br J Haematol 88:247-255.
29. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K, Oberg F. 2002. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 99:2199-2206.
30. Dirks PB, Patel K, Hubbard SL, Ackerley C, Hamel PA, Rutka JT. 1997. Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Oncogene 15:2037-2048.
31. DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal S. 1998. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 95:14811-14815.
32. Dokmanovic M, Chang BD, Fang J, Roninson IB. 2002. Retinoid-induced growth arrest of breast carcinoma cells involves co-activation of multiple growth-inhibitory genes. Cancer Biol Ther 1:24-27.
33. Dotto GP. 2000. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta 1471:M43-M56.
34. Fang L, Lee SW, Aaronson SA. 1999. Comparative analysis of p73 and p53 regulation and effector functions. J Cell Biol 147:823-830.
35. Freemantle SJ, Kerley JS, Olsen SL, Gross RH, Spinella MJ. 2002. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21:2880-2889.
36. 2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem 276:2531-2537.
37. Gianni M, Terao M, Zanotta S, Barbui T, Rambaldi A, Garattini E. 1994. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 83:1909-1921.
38. Goldstein S, Moerman EJ, Jones RA, Baxter RC. 1991. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc Natl Acad Sci USA 88:9680-9684.
39. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D, Hwang ES. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci USA 97:10978-10983.
40. Goossens K, Esquenet M, Swinnen JV, Manin M, Rombauts W, Verhoeven G. 1999. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells. Mol Cell Endocrinol 155:9-18.
41. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. 2000. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749-755.
42. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. 1996. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550.
43. Guibal FC, Moog-Lutz C, Smolewski P, Di Gioia Y, Darzynkiewicz Z, Lutz PG, Cayre YE. 2002. ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J Biol Chem 277:218-224.
44. Hayashi K, Yokozaki H, Naka K, Yasui W, Yajin K, Lotan R, Tahara E. 2000. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. Cancer Lett 151:199-208.
45. Hayflick L, Moorhead PS. 1961. The serial cutivation of human diploid cell strains. Exp Cell Res 37:585-621.
46. Hong J, Zhang G, Dong F, Rechler MM. 2002. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277:10489-10497.
47. Hsu SL, Yin SC, Liu MC, Reichert U, Ho WL. 1999. Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis. Exp Cell Res 252:332-341.
48. Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD. 2000. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Exp Cell Res 258:322-331.
49. Huang SL, Shyu RY, Yeh MY, Jiang SY. 2000. Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Mol Cell Endocrinol 159:15-24.
50. Hwa V, Oh Y, Rosenfeld RG. 1997. Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocrine 6:235-242.
51. Kazmi SM, Plante RK, Visconti V, Lau CY. 1996. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res 56:1056-1062.
52. Kim EJ, Kang YH, Schaffer BS, Bach LA, MacDonald RG, Park JH. 2002. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: Role of insulin-like growth factor binding protein-6. J Cell Physiol 190:92-100.
53. Kohring K, Zimmermann H. 1998. Upregulation of ecto-5′-nucleotidase in human neuroblastoma SH-SY5Y cells on differentiation by retinoic acid or phorbolester. Neurosci Lett 258:127-130.
54. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. 2001. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA 98:12072-12077.
55. Kucharova S, Farkas R. 2002. Hormone nuclear receptors and their ligands: Role in programmed cell death (review). Endocr Regul 36:37-60.
56. Kurie JM, Buck J, Eppinger TM, Moy D, Dmitrovsky E. 1993. 9-cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells. Differentiation 54:123-129.
57. Le Q, Soprano DR, Soprano KJ. 2002. Profiling of retinoid mediated gene expression in synchronized human SCC cells using Atlas human cDNA expression arrays. J Cell Physiol 190:345-355.
58. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P. 1990. v-Haras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 87:9178-9182.
59. Lee X, Si SP, Tsou HC, Peacocke M. 1995. Cellular aging and transformation suppression: A role for retinoic acid receptor beta 2. Exp Cell Res 218:296-304.
60. Lee MO, Han SY, Jiang S, Park JH, Kim SJ. 2000. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta. Biochem Pharmacol 59:485-496.
61. Li XS, Shao ZM, Sheikh MS, Eiseman JL, Sentz D, Jetten AM, Chen JC, Dawson MI, Aisner S, Rishi AK. 1995. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth. J Cell Physiol 165:449-458.
62. Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen GQ, Shroot B, Mercola D, Zhang XK. 1998. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol 18:4719-4731.
63. Linnala A, Lehto VP, Virtanen I. 1997, Neuronal differentiation in SH-SY5Y human neuroblastoma cells induces synthesis and secretion of tenascin and upregulation of alpha(v) integrin receptors. J Neurosci Res 49:53-63.
64. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X. 1996a. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16:1138-1149.
65. Liu M, Iavarone A, Freedman LP. 1996b. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723-31728.
66. Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR, Weissman SM. 1999. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA 96:4313-4318.
67. Liu TX, Zhang JW, Tao J, Zhang RB, Zhang QH, Zhao CJ, Tong JH, Lanotte M, Waxman S, Chen SJ, Mao M, Hu GX, Zhu L, Chen Z. 2000a. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 96:1496-1504.
68. Liu F, Qi HL, Chen HL. 2000b. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126:85-90.
69. Lotan R. 1994. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res 54: 1987s-1990s.
70. Martin JL, Coverley JA, Baxter RC. 1994. Regulation of immunoreactive insulin-like growth factor binding protein-6 in normal and transformed human fibroblasts. J Biol Chem 269:11470-11477.
71. Matsuo T, Thiele CJ. 1998. p27Kip1: A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16:3337-3343.
72. Maul RS, Chang DD. 1999. EPLIN, epithelial protein lost in neoplasm. Oncogene 18:7838-7841.
73. Murakami K, Matsuura T, Hasumura S, Nagamori S, Yamada Y, Saiki I. 2000. Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-alpha-mediated inhibition of hepatocellular carcinoma cell proliferation. Cancer Lett 151:63-70.
74. Naka K, Yokozaki H, Domen T, Hayashi K, Kuniyasu H, Yasui W, Lotan R, Tahara E. 1997. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. Differentiation 61:313-320.
75. Nervi C, Vollberg TM, George MD, Zelent A, Chambon P, Jetten AM. 1991. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp Cell Res 195:163-170.
76. Pomponi F, Cariati R, Zancai P, De Paoli P, Rizzo S, Tedeschi RM, Pivetta B, De Vita S, Boiocchi M, Dolcetti R. 1996. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood 88:3147-3159.
77. Redfern CP, Daly AK, Latham JA, Todd C. 1990. The biological activity of retinoids in melanoma cells. Induction of expression of retinoic acid receptor-beta by retinoic acid in S91 melanoma cells. FEBS Lett 273:19-22.
78. Robles SJ, Adami GR. 1998. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16:1113-1123.
79. Roninson IB, Broude EV, Chang BD. 2001. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resistance 4:303-313.
80. Schenker T, Trueb B. 1998. Down-regulated proteins of mesenchymal tumor cells. Exp Cell Res 239:161-168.
81. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109:335-346.
82. Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD, Jarrard DF. 2002. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 277:14877-14883.
83. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. 1995. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 6:1077-1088.
84. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
85. Shammas MA, Simmons CG, Corey DR, Shmookler Reis RJ. 1999. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells. Oncogene 18:6191-6200.
86. Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, Jr., LeRoith D, Fontana JA. 1993. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol 155:556-567.
87. Shimizu T, Takeda K. 2000. Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines. Cancer Res 60:4544-4549.
88. Si SP, Lee X, Tsou HC, Buchsbaum R, Tibaduiza E, Peacocke M. 1996. RAR beta 2-mediated growth inhibition in HeLa cells. Exp Cell Res 223:102-111.
89. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, Edelhoff S, Disteche C, Neubauer M, Marquardt H. 1994. Beta ig-h3: A transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13:571-584.
90. Spanjaard RA, Sugawara A, Ikeda M, Chin WW. 1995. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melanoma cells. J Biol Chem 270:17429-17436.
91. Stein GH, Drullinger LF, Soulard A, Dulic V. 1999. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19:2109-2117.
92. Sun SY, Yue P, Wu GS, El Deity WS, Shroot B, Hong WK, Lotan R. 1999. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res 59:2829-2833.
93. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. 1994. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 5:133-141.
94. Swisshelm K, Ryan K, Tsuchiya K, Sager R. 1995. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 92:4472-4476.
95. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. 2002. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62:1876-1883.
96. Wainwright LJ, Lasorella A, Iavarone A. 2001. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 98:9396-9400.
97. Weber E, Ravi RK, Knudsen ES, Williams JR, Dillehay LE, Nelkin BD, Kalemkerian GP, Feramisco JR, Mabry M. 1999. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression. Int J Cancer 80:935-943.
98. Widschwendter M, Berger J, Muller HM, Zeimet AG, Marth C. 2001. Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6:193-201.
99. Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. 2002. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 13:205-213.
100. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. 1994. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54:3580-3587.
101. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. 1999. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 59:2477-2483.
102. Yan T, Wergedal J, Zhou Y, Mohan S, Baylink DJ, Strong DD. 2001. Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6. Growth Horm IGF Res 11:368-377.
103. Zhang D, Vuocolo S, Masciullo V, Sava T, Giordano A, Soprano DR, Soprano KJ. 2001. Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression. Oncogene 20:7935-7944.
104. Zhou Y, Mohan S, Linkhart TA, Baylink DJ, Strong DD. 1996. Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells. Endocrinology 137:975-983.
105. Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM. 1997. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res 234:293-299.
106. Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C. 1996. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73:1341-1346.